146 related articles for article (PubMed ID: 23424770)
1. Cyclin D1 expression in acral melanoma: a case control study in Sarawak.
Ibrahim ZA; Narihan MZ; Ojep DN; Soosay AE; Pan KL
Malays J Pathol; 2012 Dec; 34(2):89-95. PubMed ID: 23424770
[TBL] [Abstract][Full Text] [Related]
2. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
3. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
4. Acral melanoma of the extremities: a study of 33 cases Sarawakian patients.
Zainal AI; Zulkarnaen M; Norlida DK; Syed Alwi SA
Med J Malaysia; 2012 Feb; 67(1):60-5. PubMed ID: 22582550
[TBL] [Abstract][Full Text] [Related]
5. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in melanocytic lesions of the skin.
Ramirez JA; Guitart J; Rao MS; Diaz LK
Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
[TBL] [Abstract][Full Text] [Related]
7. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.
Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D
Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187
[TBL] [Abstract][Full Text] [Related]
8. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
Gammon B; Ali L; Guitart J; Gerami P
Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
[TBL] [Abstract][Full Text] [Related]
9. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
[TBL] [Abstract][Full Text] [Related]
10. [Acral lentiginous malignant melanoma].
Meschig R; Kind P
Z Hautkr; 1989 Feb; 64(2):137-9. PubMed ID: 2655320
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C alpha associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-independent manner in human melanoma cells.
Oka M; Kageshita T; Ono T; Goto A; Kuroki T; Ichihashi M
J Invest Dermatol; 2003 Jul; 121(1):69-76. PubMed ID: 12839565
[TBL] [Abstract][Full Text] [Related]
13. Acral melanoma in Japan.
Seiji M; Takematsu H; Hosokawa M; Obata M; Tomita Y; Kato T; Takahashi M; Mihm MC
J Invest Dermatol; 1983 Jun; 80 Suppl():56s-60s. PubMed ID: 6343519
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi.
Park E; Yang S; Emley A; DeCarlo K; Richards J; Mahalingam M
Am J Dermatopathol; 2012 Feb; 34(1):41-6. PubMed ID: 22094233
[TBL] [Abstract][Full Text] [Related]
15. Characteristic distribution of melanin columns in the cornified layer of acquired acral nevus: an important clue for histopathologic differentiation from early acral melanoma.
Saida T; Koga H; Goto Y; Uhara H
Am J Dermatopathol; 2011 Jul; 33(5):468-73. PubMed ID: 21552104
[TBL] [Abstract][Full Text] [Related]
16. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
17. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
18. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
[TBL] [Abstract][Full Text] [Related]
19. Somatic activation of KIT in distinct subtypes of melanoma.
Curtin JA; Busam K; Pinkel D; Bastian BC
J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931
[TBL] [Abstract][Full Text] [Related]
20. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
